The abstract is read at the publisher; the summary is JClub's.
A MAVE-based atlas measured lysosome-specific GCase activity for >10400 GBA1 variants, covering 97% of single–amino-acid substitutions and enabling variant-level functional interpretation.
- Why it matters: Limited functional evidence for most rare GBA1 variants constrains interpretation in Gaucher disease and Parkinson’s disease, where variant effects must be linked to clinical phenotypes.
- What they did: The study used multiplexed assay of variant effect to map activity across >10400 variants, then compared results with expert pathogenicity classes and tested concordance using stable cell lines expressing individual variants.
- The result: Functional impairment was found in 94 of 186 reported variants of uncertain significance, linked to GD severity and, in Global PD Genetics Program data, to earlier PD onset and higher PD odds ratios.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.